Skip to main content

Advertisement

SpringerLink
Log in

Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To explore Chinese medicine (CM) syndrome distribution of chronic hepatitis B virus (HBV) carriers in immunotolerant phase (ITP).

Methods

One hundred and eighty-five chronic HBV carriers in ITP, seen in the Third Affiliated Hospital of Sun Yat-sen University from May 2009 to December 2010, were admitted in an observational study under the guidance of CM. Patients’ CM symptoms and signs, demographics, liver biochemistries, and qualitative HBV DNA were recorded in the questionnaires. CM syndromes were then differentiated to 15 detailed types and analyzed by generalization. Lastly, the location, pathogenic factors and nature of the disease were also assessed.

Results

When CM syndrome patterns were differentiated to 15 types, there were 27 (15%) no syndrome cases, 94 (50%) single syndrome cases and 64 (35%) compound syndromes cases. The main detailed syndromes included Liver (Gan)-qi depression (LQD), Kidney (Shen)-qi deficiency (KQD), Spleen (Pi)-qi deficiency (SQD) and Kidney-yang deficiency (KYAD). After CM syndromes generalized to five types, their frequency was Spleen-Kidney deficiency (SKD)>LQD>inner dampness-heat retention (IDHR)>Liver-Kidney deficiency (LKD)>blood stasis blocking collateral (BSBC). SKD and LQD occupied 64%. The disease location included Liver, Gallbladder (Dan), Spleen, Stomach (Wei) and Kidney. The pathogenic factors were mainly qi stagnation, qi deficiency, yang deficiency, concurrently dampness-heat and blood stasis. The deficiency syndrome was more than excess syndrome in its nature.

Conclusions

Most of chronic HBV carriers in ITP have their CM syndrome, and the most common types are SKAD, LQD. This study suggests that the natural history may be improved through breaking the state of immune tolerance or shorten the time of ITP by strengthening Spleen-Kidney and reliving Liver qi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liu J, Fan DM. He patitis Bin China. Lancet 2007;369:1582–1583.

    Article  PubMed  Google Scholar 

  2. Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 2009;51:403–410.

    Article  PubMed  Google Scholar 

  3. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010;14:1–21, vii.

    Article  PubMed  Google Scholar 

  4. World Health Organization. Hepatitis B. World Health Organization Fact Sheet No. 204 Revised October 2000. Available at: http://www.who.int/mediacentre/factsheets/fs204/en.

  5. Cornberg M, Jaroszewicz J, Manns MP, Wedemeyer H. Treatment of chronic hepatitis B. Minerva Gastroenterol Dietol 2010;56:451–465.

    CAS  PubMed  Google Scholar 

  6. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virusinduced hepatocellular carcinoma. Pathol Biol (Paris) 2010;58:273–277.

    Article  CAS  Google Scholar 

  7. Heathcote EJ. Demography and presentation of chronic hepatitis B virus infection. Am J Med 2008;121(12 Suppl):S3–S11.

    PubMed  Google Scholar 

  8. Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009;50:264–272.

    Article  CAS  PubMed  Google Scholar 

  9. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582–592.

    Article  CAS  PubMed  Google Scholar 

  10. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107.

    Article  CAS  PubMed  Google Scholar 

  11. Ohkawa K, Takehara T, Tatsumi T, Ishida H, Deguchi M, Kagita M, et al. Alterations in hepatitis B virus nucleotide sequences in a chronic virus carrier from immunotolerant to immunoactive phase. Biochem Biophys Res Commun 2010;394:574–580.

    Article  CAS  PubMed  Google Scholar 

  12. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335–352.

    Article  PubMed  Google Scholar 

  13. Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 2009;29(Suppl 1):100–107.

    Article  PubMed  Google Scholar 

  14. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942–1956.

    Article  CAS  PubMed  Google Scholar 

  15. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191–211, v.

    Article  PubMed  Google Scholar 

  16. Chen LY, Lv WL. Traditional and Western medicine progress of HBV carrier state. Chin J Integr Tradit West Med (Chin) 2008;28:379–381.

    Google Scholar 

  17. Zhu LL, Meng H, Jiang J, Gao YQ. Study on CM syndrome typing of chronic hepatitis B. Chin J Integr Tradit West Med (Chin) 2008;28:20–23.

    Google Scholar 

  18. Ye YA, Jiang F, Zhao ZM, Li ZH, Zhang L, Liu HQ, et al. Chinese medical pattern distribution of chronic type hepatitis B. J Tradit Chin Med (Chin) 2007;48:256–258.

    Google Scholar 

  19. Xu FL. Literatures’ evaluation on CM syndrome types of chronic hepatitis B. J Clin Hepatol 2008;11:109–112.

    Google Scholar 

  20. Yu CG, Wang TF, Wan X, Zhao Y, Li ZG, Yin YJ, et al. Analysis on common syndrome manifestations and syndrome factors of chronic hepatitis B. J Beijing Univ Tradit Chin Med (Chin) 2005;28:70–73.

    CAS  Google Scholar 

  21. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B. Chin J Hepatol (Chin) 2005;13:881–891.

    Google Scholar 

  22. European Association for The Study of The LEASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227–242.

    Google Scholar 

  23. Yang HZ, Zhao JA, Dai M, Li YW, Wang YZ, Guan WB, et al. Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant. World J Gastroenterol 2005;11:2004–2008.

    PubMed  Google Scholar 

  24. Zheng XY, ed. Guiding principle for clinical research on new drugs of traditional Chinese medicine. Beijing: China Medic-Pharmaeeutical Sciences and Technology Publishing House; 2002:361–388.

    Google Scholar 

  25. Zhu WF, ed. Diagnostics of traditional Chinese medicine. Beijing: China Press of Traditional Chinese Medicine; 2007:139–203.

    Google Scholar 

  26. Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune tolerant phase. Hepatology 2007;46:395–401.

    Article  PubMed  Google Scholar 

  27. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 Version). Chin J Gastroenterol 2011;16:351–366.

    Google Scholar 

  28. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550–6557.

    Article  PubMed  Google Scholar 

  29. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J 2009;122:3–4.

    PubMed  Google Scholar 

  30. Yang LS, Wang QP, Zhou JG, Jiang DX, Li SL, Su YY, et al. Study on Chinese medical syndromes of subhealth state in HBV carriers. Acta Univ Tradit Med Sinen Pharmacol Shanghai (Chin) 2008;22:34–37.

    CAS  Google Scholar 

  31. Yang LS, Wang QP, Zhou JG, Jiang DX, Li SL, Su YY, et al. Study on CM syndrome types of HBV carrier in second health condition. Chin J Integr Tradit West Med Liver Dis (Chin) 2008;18:71–73.

    CAS  Google Scholar 

  32. Mao DX, Zhu G. Ideas for syndrome differentiating and Chinese herbs using in hepatitis B. J Tradit Chin Med (Chin) 2002;43:144–145.

    Google Scholar 

  33. Yuan JQ. Chinese medicine therapeutic and understanding measurements for HBV infection in the phase of immune tolerance. Chin J Integr Tradit West Med Liver Dis (Chin) 2007;17:65–67.

    Google Scholar 

  34. Hu ZY. Progress in the mechanism of persistent HBV infection. Foreign Med Sci (Virology, Chin) 2000;7:100–103.

    Google Scholar 

  35. Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009;50:661–662.

    Article  PubMed  Google Scholar 

  36. Song J, Chen KJ. Set clinical therapeutic guideline in traditional medicine urgently. Chin J Integr Tradit West Med (Chin) 2006;26:581–584.

    Google Scholar 

  37. Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, et al. The clinical study on cronic hepatitis B treated by the four-step therapeutics of traditional Chinese medicine. J Chin Med Mater (Chin) 2006;29:748–752.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Traditional Chinese Medicine & Acupuncture Department, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, 510630, China

    He-ping Xie  (谢和平), Hong-zhi Yang  (杨宏志), Wei-kang Wu  (吴伟康), Wei-bing Guan  (关卫兵), Qian-shan Ke  (柯千山), Yong-wei Li  (李永伟), Min Dai  (戴 敏), Ge-min Xiao  (肖阁敏), Jiong-shan Zhang  (张炯善) & Yang-mei Li  (李杨湄)

Authors
  1. He-ping Xie  (谢和平)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong-zhi Yang  (杨宏志)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei-kang Wu  (吴伟康)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei-bing Guan  (关卫兵)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qian-shan Ke  (柯千山)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yong-wei Li  (李永伟)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Min Dai  (戴 敏)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ge-min Xiao  (肖阁敏)
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jiong-shan Zhang  (张炯善)
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yang-mei Li  (李杨湄)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong-zhi Yang  (杨宏志).

Additional information

Supported by Grants from the National Major Projects for AIDS and Viral Hepatitis of China (No.2008ZX10005-008)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, Hp., Yang, Hz., Wu, Wk. et al. Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase. Chin. J. Integr. Med. 20, 94–100 (2014). https://doi.org/10.1007/s11655-013-1569-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-013-1569-5

Keywords

Search

Navigation